Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA571851
Max Phase: Preclinical
Molecular Formula: C42H47N7O6
Molecular Weight: 745.88
Molecule Type: Small molecule
Associated Items:
ID: ALA571851
Max Phase: Preclinical
Molecular Formula: C42H47N7O6
Molecular Weight: 745.88
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](OCc3ccc4ccccc4n3)[C@H](N)C[C@@H]2N)[C@H](N)[C@@H](OCc2ccc3ccccc3n2)[C@@H]1OCc1ccc2ccccc2n1
Standard InChI: InChI=1S/C42H47N7O6/c43-20-35-40(52-22-28-17-14-25-8-2-5-11-33(25)48-28)41(53-23-29-18-15-26-9-3-6-12-34(26)49-29)36(46)42(54-35)55-39-31(45)19-30(44)38(37(39)50)51-21-27-16-13-24-7-1-4-10-32(24)47-27/h1-18,30-31,35-42,50H,19-23,43-46H2/t30-,31+,35-,36-,37-,38+,39-,40-,41-,42-/m1/s1
Standard InChI Key: JAZGRUVSWZNZAC-MSJSRACFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 745.88 | Molecular Weight (Monoisotopic): 745.3588 | AlogP: 3.20 | #Rotatable Bonds: 12 |
Polar Surface Area: 209.13 | Molecular Species: BASE | HBA: 13 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 9 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 13.11 | CX Basic pKa: 9.67 | CX LogP: 2.53 | CX LogD: -2.71 |
Aromatic Rings: 6 | Heavy Atoms: 55 | QED Weighted: 0.12 | Np Likeness Score: 0.47 |
1. Baussanne I, Bussière A, Halder S, Ganem-Elbaz C, Ouberai M, Riou M, Paris JM, Ennifar E, Mingeot-Leclercq MP, Décout JL.. (2010) Synthesis and antimicrobial evaluation of amphiphilic neamine derivatives., 53 (1): [PMID:20000576] [10.1021/jm900615h] |
2. Zimmermann L, Bussière A, Ouberai M, Baussanne I, Jolivalt C, Mingeot-Leclercq MP, Décout JL.. (2013) Tuning the antibacterial activity of amphiphilic neamine derivatives and comparison to paromamine homologues., 56 (19): [PMID:24083676] [10.1021/jm401148j] |
Source(1):